LLYON
li Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes.
Name LLYON
Rank No.1289
Market Cap $0.00
Fully Diluted Market Cap $0.00
Market Share %
Trading Vol/Market Cap (24H) 52,203.41%
Circulation Supply 4,362.31855546
Max Supply 0
Total Supply 4,362.31855546
Circulation Rate %
Issue Date --
The price at which the asset was first issued --
All-Time High 1147.3529425467884, 2026-05-28
Lowest Price 712.8133541417105, 2025-09-25
Public Blockchain LLYON
Introduction li Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes.
Sector
Social Media
Fund Flow Analysis
|
Buy(LLYON) |
Sell(LLYON) |
Net Inflow |
| Big |
0.000 |
0.000 |
0.000 |
| Medium |
0.000 |
58.898 |
-58.898 |
| Small |
20.063 |
102.813 |
-82.749 |
| Total |
20.063 |
161.711 |
-141.647 |
etfindex:mc_etfindex_source Disclaimer: Data provided by cmc and should not be considered as investment advice.
